Dr. Meijing Wu is described by friends and colleagues as a distinguished biostatistician and “a kind and generous friend who ...

Women's health innovator Evofem Biosciences, Inc. ("Evofem" or "the Company") today announced financial results for the third quarter and nine-month period ended September 30, 2024. Highlights ...

Revenues in the fiscal second quarter of 2025 decreased 3% to $201,000, largely due to decreased sales to veterinary clinics. The decrease was partially offset by a 24% increase in sales to ...

Radiate Holdco, LLC ("Radiate") announced today that it released its Third Quarter 2024 financial results on its secure investor website. The financial results were provided in accordance with the ...

Attorneys for the school district say that the legal action is in part due to self-funded insurance plans that has possibly ...

By using automated content recognition, Beatgrid can measure cross-platfrom ad exposure by individual as well as the ...

Sarclisa recommended for EU approval by the CHMP to treat transplant-ineligible newly diagnosed multiple myelomaRecommendation based on IMROZ ...

Sanofi said that Sarclisa, its treatment for plasma cell cancer, was recommended for EU approval by the European Medicines Agency. The agency's Committee for Medicinal Products for Human Use ...

Life sciences expert Jennie Taveras has joined STO Building Group to lead the company’s growth in the life sciences sector ...

2 Top Growth Stocks to Buy on the Dip was originally published by The Motley Fool ...

Most people don't enjoy getting shots for treatments or vaccines. So, researchers are working to create more medicines, such as those made from messenger RNA (mRNA), that can be sprayed and inhaled. A ...

Baidu CEO’s life sciences startup sees artificial intelligence as the inevitable force driving transformation in drug ...